Skip to main content
普昂医疗 logo

普昂医疗 — Investor Relations & Filings

Ticker · 920069 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 31 across all filing types
Latest filing 2026-04-22 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920069

About 普昂医疗

http://www.promisemed.cn/

Puao Medical specializes in the development and manufacturing of precision medical consumables, with a core focus on diabetes care and infusion therapy. The product portfolio includes insulin pen needles, safety lancets, blood glucose monitoring accessories, and various surgical instruments. By integrating advanced automated production processes and high-precision molding technologies, the company delivers disposable medical devices designed for safety, reliability, and patient comfort. Puao Medical serves a global clientele across clinical and home care settings, maintaining international quality standards and certifications to ensure compliance with rigorous healthcare requirements.

Recent filings

Filing Released Lang Actions
国金证券股份有限公司关于普昂（杭州）医疗科技股份有限公司开展外汇套期保值业务的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report by the sponsor institution Guojin Securities Co., Ltd. regarding the foreign exchange hedging business of Puang (Hangzhou) Medical Technology Co., Ltd. It includes purpose, business scope, risk analysis, risk control measures, and approval procedures related to the foreign exchange hedging business. The document is not a financial report, earnings release, or regulatory filing per se, but a formal verification opinion by the sponsor institution as part of continuous supervision and regulatory compliance. It does not announce voting results, nor is it a management or board change announcement. It is not a call transcript or capital update. The document is a formal audit or verification opinion related to a specific business activity, which fits the category of Audit Report / Information (AR). The document length is 2911 characters, which is substantive and contains detailed analysis and opinions, not just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2026
2026-04-22 Chinese
国金证券股份有限公司关于普昂（杭州）医疗科技股份有限公司使用闲置自有资金进行委托理财的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from a sponsoring institution (Guojin Securities Co., Ltd.) regarding the use of idle funds by Puang (Hangzhou) Medical Technology Co., Ltd. for entrusted financial management. It details the purpose, amount, decision-making process, risk analysis, and supervisory opinions related to the use of idle funds for financial products. The document is regulatory in nature, focusing on compliance with listing rules and supervisory guidelines, and does not contain financial statements or earnings data. It is not an annual or interim report, earnings release, or capital update. It is also not a simple announcement but a detailed regulatory compliance opinion. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and miscellaneous regulatory announcements that do not fit other categories. The document length is short (1642 characters), and it is not merely announcing a report but providing a regulatory opinion, so it is not RPA. Confidence is high due to clear regulatory and compliance content without financial reporting.
2026-04-22 Chinese
第二届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 16th meeting of the second board of directors of Puang (Hangzhou) Medical Technology Co., Ltd. It includes multiple agenda items such as approval of the 2025 annual report, 2026 first quarter report, financial budgets, various management and audit reports, remuneration plans, capital changes, governance documents, and other corporate matters. The document repeatedly references that the actual reports and documents are disclosed separately on the Beijing Stock Exchange information disclosure platform, indicating this document itself is a board meeting resolution announcement rather than the reports themselves. The document is not a full annual report, quarterly report, or earnings release, but rather a board/management information announcement about decisions and approvals made by the board. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (over 10,000 characters) and detailed content support this classification with high confidence.
2026-04-22 Chinese
关于召开2025年年度股东会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2025 Annual General Meeting (AGM) of 普昂（杭州）医疗科技股份有限公司. It includes information about the meeting date, voting methods (including online voting), agenda items to be discussed and voted on (such as the 2025 annual report, financial budget, financial statements, board work report, independent director report, dividend distribution plan, director remuneration, capital changes, appointment of accounting firm, and internal management system revisions). It also provides instructions for shareholder registration and proxy voting. The document does not contain the actual annual report or financial statements but rather the notice and agenda for the AGM. The document length is 4043 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, including notices and agendas.
2026-04-22 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transaction Management System'. It is a detailed internal policy document outlining the principles, scope, procedures, and responsibilities related to managing related party transactions within the company. It includes sections on definitions, principles, approval processes, and responsibilities. The document is issued and approved by the company's board and is dated April 23, 2026. There is no indication that this is a financial report, earnings release, or regulatory filing announcement. It is a governance-related document detailing internal rules and procedures for managing related party transactions, which falls under governance information rather than financial reporting or announcements. Therefore, the appropriate classification is Governance Information (CGR). The document length (6570 characters) and content support this classification with high confidence.
2026-04-22 Chinese
外汇套期保值交易管理制度
Governance Information Classification · 95% confidence The document is titled as a "Foreign Exchange Hedging Transaction Management System" issued by the company's board, detailing internal policies, procedures, risk management, and approval processes related to foreign exchange hedging activities. It includes sections on operational principles, approval authority, internal workflows, risk management, and disclosure obligations. The document is a regulatory or governance policy document rather than a financial report or announcement of financial results. It is not an annual or interim report, earnings release, or capital update. It is also not a notice of voting results, director dealings, or legal proceedings. The document is a formal internal governance policy related to financial risk management and compliance. Given the nature of the content focusing on internal rules and procedures, the most appropriate classification is Governance Information (CGR). The document length is under 5,000 characters, but it is not merely an announcement of a report publication, so RPA is not suitable. Therefore, the classification is CGR with high confidence.
2026-04-22 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.